Dan Dobry is a CDMO industry innovator and the Chief Strategy Officer of Bend Bioscience. They have extensive experience as a director and executive in the pharmaceutical services and biotechnology industry, with a strong focus on strategic planning and business development. Dan previously worked as Vice President at Bend Research, contributing to the development of advanced drug delivery technologies and holding multiple patents in the field. They co-founded Bend Bioscience and continue to play a pivotal role in their current operations. Dan earned a Bachelor’s degree in Chemical Engineering from Oregon State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices